Ballina, Co. Mayo, Ireland
The world's first economically sustainable production of germ-free eggs and antibodies.
• Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry housing & husbandry, in specific poultry research technologies to GMP standards and in avian transgenics.
• Germ-free eggs are preferred as currently eggs produced from normal or SPF laying flocks can be infected with bacteria and viruses therefore Germ-free eggs provide many advantages over current sources of eggs including: A safe, biosecure, large scale, flexible and cost effective biomanufacturing platform for the production of vaccines and therapeutic proteins
• No contamination from eggs of batches of vaccines / therapeutic proteins / antisera
- Leads to cost saving and greater continuity of supply of finished product
- Removes risk of egg-derived contamination of pharmaceutical / vaccine manufacturing facilities
• GF eggs are produced to GMP fully compliant with USDA Memo 800.65 and European Pharmacopoeia requirements.
No key contacts have been added to this profile yet.
This is the company profile page for Ovagen Group on the Pharma Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.